| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 09/01/2005 | CA2555939A1 Treatment of abnormalities of the first metatarsophalangeal joint of the foot |
| 08/31/2005 | EP1568769A1 ENA NUCLEIC ACID DRUGS MODIFYING SPLICING IN mRNA PRECURSOR |
| 08/31/2005 | EP1568685A1 Aminoadamantane derivatives as therapeutic agents |
| 08/31/2005 | EP1567182A2 Preventing desensitization of receptors |
| 08/31/2005 | EP1567022A1 Sustained improver of muscular fatigue |
| 08/31/2005 | EP1278723B1 P-(sulfonyl)-aryl and -heteroaryl amines |
| 08/31/2005 | EP1268445B1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases |
| 08/31/2005 | EP1169060B1 Sodium channel blocker compositions and the use thereof |
| 08/31/2005 | CN1662664A Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions |
| 08/31/2005 | CN1662519A Heterocyclic compounds as glycine transport inhibitors |
| 08/31/2005 | CN1662511A Pharmaceutical salts of reboxetine |
| 08/31/2005 | CN1662505A Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same |
| 08/31/2005 | CN1662243A Pharmaceutical composition |
| 08/31/2005 | CN1662242A Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 08/31/2005 | CN1660849A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 08/31/2005 | CN1660839A Chemical compounds |
| 08/31/2005 | CN1660435A New drug combinations |
| 08/31/2005 | CN1660291A Chinese materia medica preparation for treating spasm of eye and facial muscles, and preparing method |
| 08/31/2005 | CN1216869C Polymorphic crystalline forms of celecoxib |
| 08/31/2005 | CN1216633C Medicine for treating cardio-cerebral vascular diseases |
| 08/31/2005 | CN1216598C 药物用途 Drug use |
| 08/30/2005 | US6936633 Pyrrolidinone derivatives |
| 08/30/2005 | US6936613 for treatment of central nervous system diseases and disorders, which are responsive to modulation of the Gamma amminobutyric acid (GABA) receptor complex, and for inducing and maintaining anesthesia, sedation and muscle relaxation |
| 08/30/2005 | US6936606 Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 08/30/2005 | US6936585 Corticotropin releasing factor 2 receptor agonists |
| 08/30/2005 | CA2103887C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 08/25/2005 | WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both |
| 08/25/2005 | US20050187220 Alleviating pain, treating a locomotive disorders, stress, depression, epilepsy, Alzheimer's disease, senile dementia, general cognitive dysfunction, drug and alcohol abuse, hypotension, hypertension, tinnitus, pruritus, defective hearing, anorexia, obesity; chemical synthesis |
| 08/24/2005 | EP1566387A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 08/24/2005 | EP1566181A1 Novel medicament for ameliorating neurotransmission dysfunction diseases |
| 08/24/2005 | EP1566178A1 Remedy for fibromyalgia |
| 08/24/2005 | EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use |
| 08/24/2005 | EP1565175A1 Use of a histone deacetylase inhibitor for treating muscular dystrophies |
| 08/24/2005 | EP1401841B1 Substituted 1-oxa-2,8-diaza-spiro 4,5]dec-2-ene derivatives as medicaments for the treatment of pain |
| 08/24/2005 | EP1392307B1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 08/24/2005 | EP1019075B1 Beta 2-adrenergic receptor agonists |
| 08/24/2005 | CN1659288A Method to inhibit cell growth using oligonucleotides |
| 08/24/2005 | CN1659148A Aryloximes |
| 08/24/2005 | CN1659147A Pyridazine derivatives |
| 08/24/2005 | CN1659144A Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 08/24/2005 | CN1659141A 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders |
| 08/24/2005 | CN1658897A Methods for treating muscle injuries |
| 08/24/2005 | CN1658893A G-type peptides to ameliorate atherosclerosis |
| 08/24/2005 | CN1658886A Hormone replacement therapy |
| 08/24/2005 | CN1658866A Tri-substituted heteroaryls and methods of making and using the same |
| 08/24/2005 | CN1658863A Severe sepsis preventive therapeutic agent |
| 08/24/2005 | CN1658861A Novel formate salt of o-desmethyl-venlafaxine |
| 08/24/2005 | CN1658853A Monotherapy for the treatment of amyotrophic lateral sclerosis with cyclooxygenase-2 (COX 2) inhibitor(s) |
| 08/24/2005 | CN1658852A Amidine derivatives for treating amyloidosis |
| 08/24/2005 | CN1658847A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 08/24/2005 | CN1658767A Composition for modulating a physiological reaction or inducing an immune response |
| 08/23/2005 | US6933310 treating motor neuron diseases by administering 3-methyl-1-phenyl-2-pyrazoline-5-one or a salt thereof |
| 08/23/2005 | US6933304 Antitumor agents, osteoporosis |
| 08/23/2005 | US6933113 Modulation of endogenous gene expression in cells |
| 08/23/2005 | US6932973 Peptides which stimulate the expression of the cytokines of inflammation and promote tissue regeneration |
| 08/23/2005 | US6932969 Ig fractions having immunomodulatory activity |
| 08/23/2005 | CA2119782C Carbamate analogs of thiaphysovenine, pharmaceutical compositions, and method for inhibiting cholinesterases |
| 08/18/2005 | WO2005074962A1 Muscular tension-elevating agent |
| 08/18/2005 | WO2005074919A1 Diurea derivatives |
| 08/18/2005 | WO2003004608A3 Drug metabolizing enzymes |
| 08/18/2005 | US20050182057 Aryl N-cyanoguanidines and methods related thereto |
| 08/18/2005 | US20050182042 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 08/18/2005 | US20050182003 Drugs to be used in gene therapy for recessively transmitted genetic disease |
| 08/18/2005 | US20050181066 Novel use of guanylate cyclase activators for the treatment of respiratory insufficiency |
| 08/18/2005 | CA2551566A1 Diurea derivatives |
| 08/17/2005 | EP1563843A1 Botulinum toxins for treating various disorders and associated pain |
| 08/17/2005 | EP1562570A1 Treatment of amyotrophic lateral sclerosis with nimesulide |
| 08/17/2005 | EP1429617A4 Methods for sterilizing preparations of digestive enzymes |
| 08/17/2005 | EP1237552B1 Combination of lumilysergol and riluzole for preventing and/or treating motoneuronal diseases |
| 08/17/2005 | EP1023445B1 Cadherin derived growth factor and the application thereof |
| 08/17/2005 | CN1656094A 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders |
| 08/17/2005 | CN1656093A 3-substituted quinuclidines and their use |
| 08/17/2005 | CN1656082A Protein kinase inhibitors |
| 08/17/2005 | CN1656079A Pyrazole compounds and pharmaceutical compositions comprising the compound |
| 08/17/2005 | CN1656070A Melanocortin receptor ligands |
| 08/17/2005 | CN1655845A Use of IL-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases |
| 08/17/2005 | CN1655819A Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 08/17/2005 | CN1655814A Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 08/17/2005 | CN1655809A Compositions and methods for treating and preventing necrosis |
| 08/17/2005 | CN1655787A Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 08/17/2005 | CN1655785A N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders |
| 08/17/2005 | CN1655774A Bis-aromatic alkanols |
| 08/17/2005 | CN1215080C Substd. sapogenins and their use |
| 08/17/2005 | CN1214790C Method for preparing isoxazole substituted composition for treating inflammation |
| 08/17/2005 | CN1214789C Delta 9 tetrahydrocannabinol (delta 9 THC) solution metered dose inhalers and methods of use |
| 08/16/2005 | US6930188 Stable hydrate of a muscarinic receptor antagonist |
| 08/16/2005 | US6930123 Benz(f)indole compounds useful for Inflammatory Diseases |
| 08/16/2005 | US6930111 Substituted heterocyclic compounds |
| 08/16/2005 | US6930085 G-type peptides to ameliorate atherosclerosis |
| 08/11/2005 | WO2005072720A1 Use of phenylbutyrate for treatment of spinal muscular atrophy |
| 08/11/2005 | US20050176964 Nicotinamide derivatives useful as p38 inhibitors |
| 08/11/2005 | US20050176927 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; diagnosis |
| 08/11/2005 | US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde |
| 08/11/2005 | US20050176770 Novel 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 08/11/2005 | US20050176762 Tachykinin receptor subtypes NK3 and NK2 (NK neurokinin); various diseases including respiratory system disorders, autoimmune disorders, psychological disorders, skin disorders |
| 08/11/2005 | US20050176756 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 08/11/2005 | US20050176735 For use as anxiolytic, antiepileptic, sedative-hypnotic agents and skeletal muscle relaxants |
| 08/11/2005 | US20050176723 (Halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 08/11/2005 | US20050176720 Pharmaceutical composition for the treatment of CNS and other disorders |
| 08/11/2005 | US20050176714 Pyridazine derivatives |